1. Home
  2. CERO vs JNVR Comparison

CERO vs JNVR Comparison

Compare CERO & JNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • JNVR
  • Stock Information
  • Founded
  • CERO 2017
  • JNVR 2018
  • Country
  • CERO United States
  • JNVR United States
  • Employees
  • CERO N/A
  • JNVR N/A
  • Industry
  • CERO
  • JNVR Finance: Consumer Services
  • Sector
  • CERO
  • JNVR Finance
  • Exchange
  • CERO Nasdaq
  • JNVR Nasdaq
  • Market Cap
  • CERO 8.4M
  • JNVR 7.0M
  • IPO Year
  • CERO N/A
  • JNVR 2023
  • Fundamental
  • Price
  • CERO $2.06
  • JNVR $5.04
  • Analyst Decision
  • CERO
  • JNVR
  • Analyst Count
  • CERO 0
  • JNVR 0
  • Target Price
  • CERO N/A
  • JNVR N/A
  • AVG Volume (30 Days)
  • CERO 737.7K
  • JNVR 14.3K
  • Earning Date
  • CERO 02-24-2025
  • JNVR 03-27-2025
  • Dividend Yield
  • CERO N/A
  • JNVR N/A
  • EPS Growth
  • CERO N/A
  • JNVR N/A
  • EPS
  • CERO N/A
  • JNVR N/A
  • Revenue
  • CERO N/A
  • JNVR $1,820,969.00
  • Revenue This Year
  • CERO N/A
  • JNVR N/A
  • Revenue Next Year
  • CERO N/A
  • JNVR N/A
  • P/E Ratio
  • CERO N/A
  • JNVR N/A
  • Revenue Growth
  • CERO N/A
  • JNVR N/A
  • 52 Week Low
  • CERO $1.70
  • JNVR $3.37
  • 52 Week High
  • CERO $1,095.00
  • JNVR $11.84
  • Technical
  • Relative Strength Index (RSI)
  • CERO 37.15
  • JNVR 45.24
  • Support Level
  • CERO $1.70
  • JNVR $4.91
  • Resistance Level
  • CERO $2.22
  • JNVR $5.35
  • Average True Range (ATR)
  • CERO 0.30
  • JNVR 0.38
  • MACD
  • CERO 0.27
  • JNVR -0.04
  • Stochastic Oscillator
  • CERO 24.32
  • JNVR 9.20

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

About JNVR Janover Inc.

Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.

Share on Social Networks: